Icaria Medical's CardioSense: Cardiovascular pre-diagnosis in less than 60 seconds

Spain

5 min read

Nov 04, 2019

By Amalia González

The company's CPO and co-founder, Anna Nicolau. Source: Twitter

Icaria Medical is seeking clinical validation and funding for its AI-based monitor, which measures blood pressure continuously and non-invasively

Icaria Medical was founded in July 2018 as a spin-off of the Polytechnic University of Catalonia (UPC) and in possession of the university's two CardioSense patents. In order to gain medical-product certification, the company needs to pass a first clinical study and a regulatory clinical study, a process that requires three years and three investment rounds of €500,000 (currently underway), €2m and €6–8m, respectively.
The co-founders include Vincent Ribas, an AI PhD holder and a researcher with six patents in medical technologies. He has more than 20 years of experience as an ent...

The rest of the content is only available if you are logged in.

DATABASE

INSIGHTS

RESEARCH & ANALYSIS

FOLLOW US